The Nexus of Pathophysiology & Therapeutics (NPT) officially begins its publishing journey in 2026 as a peer-reviewed, open-access scientific journal dedicated to advancing biomedical science and therapeutics.
NPT was established to provide a platform for high-quality research across pathophysiology, pharmacology, therapeutics, diagnostics and biomarkers, biomedical sciences, and translational research. The journal aims to promote rigorous scientific work that contributes to a deeper understanding of disease mechanisms and advances in therapeutic science.
From the outset, NPT is committed to scientific rigor, integrity, multidisciplinary expertise, and international collaboration. The journal brings together expertise across diverse areas of biomedical, pharmaceutical, and clinical sciences through its developing international Editorial Board.
The launch of NPT marks the beginning of a long-term commitment to supporting high-quality scientific communication and fostering meaningful connections between disease biology, pathophysiology, pharmacology, and therapeutic innovation.
We look forward to building a strong international scientific community and providing a trusted platform for researchers and clinicians worldwide.
NPT — advancing pathophysiology and therapeutics through rigorous science.
